Glaukos CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Tomas Navratil, CHIEF DEVELOPMENT OFFICER of GLAUKOS Corp, sold 1,615 shares of common stock on September 25, 2026.
NYSE
Tomas Navratil, CHIEF DEVELOPMENT OFFICER of GLAUKOS Corp, sold 1,457 shares of common stock on September 16, 2026.
NYSE
Tomas Navratil, CHIEF DEVELOPMENT OFFICER of GLAUKOS Corp, sold 13,744 shares of common stock on August 28, 2026.
NYSE
Gilbert H Kliman, a Director of GLAUKOS Corp, sold 2,500 shares of common stock on August 19, 2026 for $190.00 per share.
NYSE
Joseph E Gilliam, PRESIDENT & COO of GLAUKOS Corp, sold 60,000 shares of common stock on August 11, 2026.
NYSE
Alex R. Thurman, SVP & CHIEF FINANCIAL OFFICER of GLAUKOS Corp, sold 20,000 shares of common stock on August 7, 2026 for $180.13 per share.
NYSE
Leana Wen, a Director of GLAUKOS Corp, sold 525 shares of common stock on July 31, 2026 for $167.63 per share.
NYSE
Alex R. Thurman, SVP & CHIEF FINANCIAL OFFICER of GLAUKOS Corp, sold 10,000 shares of common stock on July 16, 2026 for $160.00 per share.
NYSE
Alex R. Thurman, SVP & CHIEF FINANCIAL OFFICER of GLAUKOS Corp, sold 10,000 shares of common stock on July 9, 2026 for $155.00 per share.
NYSE
Alex R. Thurman, SVP & Chief Financial Officer of Glaukos Corp, reported transactions involving common stock and stock options on July 6, 2026, executed under a Rule 10b5-1 trading plan.
NYSE
Glaukos Corp. Chief Development Officer Tomas Navratil reported the sale of common stock under a pre-arranged trading plan.
NYSE
Glaukos Corporation's Chairman & CEO, Thomas William Burns, reported a transaction involving the withholding of shares for tax obligations and a net increase in directly held common stock.
NYSE
Glaukos Corp President & COO Joseph E. Gilliam reported a transaction involving the sale of 1,056 shares of common stock.
NYSE
Glaukos Corp. reports a transaction involving shares held by Chief Development Officer Tomas Navratil.
NYSE
Glaukos Corp. Chief Development Officer Tomas Navratil sold 1,537 shares of common stock for $130.68 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Director Leana Wen acquired 1,878 restricted stock units and 2,987 stock options as part of the Glaukos Corporation director compensation policy.
NYSE
Director Aimee S. Weisner acquired 1,878 restricted stock units and 2,987 stock options as part of the Glaukos Corporation director compensation policy.
NYSE
Director Denice Torres acquired 1,878 restricted stock units and 2,987 stock options as part of the Glaukos Corporation director compensation policy.
NYSE
Director Mark Foley acquired 1,878 restricted stock units and 2,987 stock options as part of the Glaukos Director Compensation Policy.
NYSE
Director David F. Hoffmeister was granted restricted stock units and stock options as part of the Glaukos Corporation director compensation policy.
NYSE
Director Gilbert H. Kliman acquired 1,878 restricted stock units and 2,987 stock options as part of the Glaukos Corporation director compensation policy.
NYSE
Director Marc Stapley acquired 1,878 restricted stock units and 2,987 stock options as part of the Glaukos Corporation director compensation policy.
NYSE
Glaukos Corporation director David F. Hoffmeister exercised 15,000 stock options at a price of $24.69 per share.
NYSE
Glaukos Corporation Director Gilbert H. Kliman exercised 5,000 stock options and subsequently sold the shares.
NYSE
Director Gilbert H. Kliman exercised 5,000 stock options and subsequently sold the shares in a routine transaction.
NYSE
Glaukos Corporation CFO Alex R. Thurman exercised 10,000 stock options and sold the resulting shares under a 10b5-1 plan.
NYSE
Glaukos Corporation President and COO Joseph E. Gilliam sold 19,573 shares of common stock at an average price of $143.54.
NYSE
Director Leana Wen sold 1,700 shares of Glaukos Corporation common stock at a price of $143.35 per share.
NYSE
Glaukos Corp. Chief Development Officer Tomas Navratil sold shares valued at over $1.3 million under a pre-arranged trading plan.
NYSE
Glaukos Corp. Chief Development Officer Tomas Navratil reported a transaction involving the withholding of shares for tax obligations and an adjustment to his beneficial ownership of common stock.